Parent IDIQ award: CRO support for ncats drug substance development and manufacture
Ended Awarded Last action
- Contract number
- HHSN271201700009I
- Awardee
-
Bachem Americas Inc. UEI ULM6JMNK5L83
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $2,433,805 obligated
Award facts
- Opportunity
-
- N01TR172001 Solicitation number
- CRO Support for NCATS Drug Substance Development and Manufacture Award Notice · Posted Mar 1, 2016
- Combined order value
-
- $2,433,805 Current, with exercised options
- $2,474,727 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 10% used
- $24,598,861.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Manufacture of 150 GN of cgmp PTH-IA | National Institute on Drug Abuse (NIH) | $597,350 | |
| Manufacture of 1 KG of cgmp l-ENK | National Institute on Drug Abuse (NIH) | $827,788 | |
| Manufacture of 200 GN of cgmp PTH-IA | National Institute on Drug Abuse (NIH) | $1,008,668 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$5,000 | |
| Other Administrative Action | $0 | |
| Original award | $5,000 |
Quick answers
Who was awarded contract HHSN271201700009I?
HHSN271201700009I was awarded to Bachem Americas Inc. by National Institute on Drug Abuse (National Institutes of Health) on March 31, 2017.
How much is contract HHSN271201700009I worth?
Orders under HHSN271201700009I have obligated $2,433,805. Their combined potential value, with all options, is $2,474,727. HHSN271201700009I's own ceiling is $24,598,861.
How many orders have been placed under contract HHSN271201700009I?
3 orders have been placed under HHSN271201700009I, the latest on March 29, 2022.
Which agency awarded contract HHSN271201700009I?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201700009I, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Who can order from contract HHSN271201700009I?
HHSN271201700009I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN271201700009I part of a contract vehicle?
Yes. HHSN271201700009I is part of CRO Support for NCATS Drug Substance Development and Manufacture.
Was contract HHSN271201700009I competed?
The extent of competition for HHSN271201700009I was full and open competition. The government received 10 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV